Inbiose
EMEA
Ghent
,
Belgium
Scaleup
FOUNDED
2013
HEADCOUNT
21-100
FUNDING
Privately held
Keywords:
precision_fermentation, synthetic_biology, metabolic_engineering, bacteria, prebiotics, nutraceuticals
BUSINESS
Inbiose is a Ghent University spin-off that develops and licenses fermentation processes for human milk oligosaccharides (HMOs) such as 2'-fucosyllactose and other complex carbohydrates. It operates a GlycoActives platform combining precision fermentation and synthetic biology, supplying ingredients for infant nutrition, food, pharma and cosmetics. It runs a licensing-plus-production business model.
BIOTECH INVOLVEMENT
Core; uses engineered microbial strains in precision fermentation to produce HMOs (incl. 2'-fucosyllactose) and other rare carbohydrates from simple sugars.
TECHNOLOGY PLATFORM
GlycoActives precision-fermentation platform
PRIMARY PRODUCTS
human milk oligosaccharides (2'-fucosyllactose and other HMOs); rare/complex carbohydrates